Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Tufts University · University of Alabama at Birmingham · +17 more institutions
Indexed incrossrefpubmed
Abstract
Background
Glucagon-like peptide 1 receptor agonists and combination medications (hereafter collectively referred to as GLP-1s) are shifting the treatment landscape for obesity. However, real-world challenges and limited clinician and public knowledge on nutritional and lifestyle interventions can limit GLP-1 efficacy, equitable results, and cost-effectiveness.
Objectives
We aimed to identify pragmatic priorities for nutrition and other lifestyle interventions relevant to GLP-1 treatment of obesity for the practicing clinician.
Citation impact
67
total citations
- FWCI
- 61.23
- Percentile
- 100%
- References
- 265
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Obesity
- Medicine
- Alternative medicine
- Gerontology
- Association (psychology)
- Family medicine
- Internal medicine
- Psychology
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.
Funding
- RFRockefeller Foundation
- NANational Association of Chain Drug Stores Foundation
- POPatient-Centered Outcomes Research Institute
- NBNeurocrine Biosciences
- RLReShape Lifesciences
- NINational Institutes of HealthAwards: 2R01 HL115189, U24 DK132733, P30 DK04056, UE5 DK137285
- SKSuomen Kardiologinen Seura
- LSLife Sciences, University of California, Los Angeles
- GGoodRx